» Articles » PMID: 3863141

Gene Mapping and Leader Polypeptide Sequence of Human Glucocerebrosidase: Implications for Gaucher Disease

Overview
Specialty Science
Date 1985 Oct 1
PMID 3863141
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Analysis of immunologic cross-reacting material in Chinese hamster-human somatic cell hybrids allowed assignment of the structural gene for glucocerebrosidase (glucosylceramidase; beta-D-glucosyl-N-acylsphingosine glucohydrolase, EC 3.2.1.45) to chromosome 1 bands q21-q32. In situ hybridization of a radiolabeled human glucocerebrosidase cDNA to high resolution human chromosomes demonstrated that a single locus encoding glucocerebrosidase is on 1q21, adjacent to a region of chromosome 1 (1qh) abundant in structural heteromorphisms. We also have identified a hydrophobic leader polypeptide encoded by this locus, permitting a more complete description of the biosynthesis of the enzyme. These results suggest that the type-specific protein polymorphisms in Gaucher disease result from mutations at this single locus, whose segregation might be followed by linkage to visible chromosomal heteromorphisms.

Citing Articles

The genetic basis of multiple system atrophy.

Tseng F, Foo J, Mai A, Tan E J Transl Med. 2023; 21(1):104.

PMID: 36765380 PMC: 9912584. DOI: 10.1186/s12967-023-03905-1.


Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review.

Behl T, Kaur G, Fratila O, Buhas C, Judea-Pusta C, Negrut N Transl Neurodegener. 2021; 10(1):4.

PMID: 33446243 PMC: 7809876. DOI: 10.1186/s40035-020-00226-x.


A novel mutation deep within intron 7 of the GBA gene causes Gaucher disease.

Malekkou A, Sevastou I, Mavrikiou G, Georgiou T, Vilageliu L, Moraitou M Mol Genet Genomic Med. 2020; 8(3):e1090.

PMID: 31943857 PMC: 7057115. DOI: 10.1002/mgg3.1090.


Glucocerebrosidase and its relevance to Parkinson disease.

Do J, McKinney C, Sharma P, Sidransky E Mol Neurodegener. 2019; 14(1):36.

PMID: 31464647 PMC: 6716912. DOI: 10.1186/s13024-019-0336-2.


Gaucher disease: Progress and ongoing challenges.

Mistry P, Lopez G, Schiffmann R, Barton N, Weinreb N, Sidransky E Mol Genet Metab. 2016; 120(1-2):8-21.

PMID: 27916601 PMC: 5425955. DOI: 10.1016/j.ymgme.2016.11.006.


References
1.
Devine E, Smith M, Desnick R . Regional assignment of the structural gene for human acid beta-glucosidase to q42 leads to qter on chromosome 1. Cytogenet Cell Genet. 1982; 33(4):340-4. DOI: 10.1159/000131781. View

2.
Ginns E, Brady R, Pirruccello S, Moore C, Sorrell S, Furbish F . Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease. Proc Natl Acad Sci U S A. 1982; 79(18):5607-10. PMC: 346953. DOI: 10.1073/pnas.79.18.5607. View

3.
Ginns E, Tegelaers F, Barneveld R, GALJAARD H, Reuser A, Brady R . Determination of Gaucher's disease phenotypes with monoclonal antibody. Clin Chim Acta. 1983; 131(3):283-7. DOI: 10.1016/0009-8981(83)90097-9. View

4.
Barneveld R, Keijzer W, Tegelaers F, Ginns E, Geurts van Kessel A, Brady R . Assignment of the gene coding for human beta-glucocerebrosidase to the region q21-q31 of chromosome 1 using monoclonal antibodies. Hum Genet. 1983; 64(3):227-31. DOI: 10.1007/BF00279398. View

5.
Gravel R, Leung A . Complementation analysis in Gaucher disease using single cell microassay techniques. Evidence for a single "Gaucher gene". Hum Genet. 1983; 65(2):112-6. DOI: 10.1007/BF00286645. View